GILEAD SCIENCES, INC. (GILD) revenue & profit
GILEAD SCIENCES, INC. (GILD): revenue $29.4B, net income $8.5B in 2025; latest quarter +10.2% year over year. From SEC filings.
$29.4BRevenue 2025
TickerGILD (Nasdaq)
IndustryHealthcare · Biological Products, (No Diagnostic Substances)
Revenue 2025$29.4B
Net income 2025$8.5B
Net margin28.9%
Annual revenue growth+2.4%
Latest quarter (2026 Q2) · Revenue$7.8B
vs. same quarter last year+10.2%
Latest quarter · Net income-$10.5B
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $27.3B | $4.6B | |
| 2023 | $27.1B | $5.7B | |
| 2024 | $28.8B | $480M | |
| 2025 | $29.4B | $8.5B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.